Form 4: Surmodics SVP of HR, President IVD, Joseph J. Stich, Reports Stock Transactions
SEC Form 4
Joseph J. Stich, SVP of HR and President IVD at Surmodics Inc, reports the acquisition and disposal of common stock and derivative securities.
Summary
- On August 21, 2024, Joseph J. Stich, SVP of HR, President IVD of Surmodics Inc, executed transactions involving the company's common stock and derivative securities.
- Stich acquired 21,285 shares of common stock through the exercise of employee stock options at a price of $33.20.
- He then disposed of 19,434 shares of common stock to cover tax obligations at a price of $40.06.
- Following these transactions, Stich directly owns 63,971 shares of Surmodics Inc common stock.
- The reported transactions also involve employee stock options, with 21,285 options exercised at a price of $33.20, which were fully vested.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions by an executive. The exercise of options is generally positive, but the sale to cover taxes is a standard practice.
Positives
- The exercise of stock options demonstrates the executive's confidence in the company's future prospects.
Negatives
- The sale of shares to cover tax obligations, while common, could be perceived negatively by some investors.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock option exercises and subsequent sales to cover taxes are a common practice across publicly traded companies.
- The specific details of the transactions, such as the exercise price and sale price, are specific to Surmodics and its compensation plans.
- Comparing the percentage of shares sold for tax obligations to industry averages could provide further context.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they reflect routine executive compensation activities.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Phase end date for ESPP shares included in the report. |
| 08/21/2024 | Date of the stock option exercise and share disposal. |
| 08/23/2024 | Date of signature for the report. |
| 11/28/2024 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.